TYMS and lung adenocarcinoma: To examine the relationship between TS overexpression and somatic mutations in non-PanNET samples, we analyzed TS expression in patients with 5 different tumor subtypes: prostate, pancreatic, lung adenocarcinoma, lung squamous carcinoma, and cutaneous melanoma, using data collected from The Cancer Genome Atlas (48) and the Clinical Proteomic Tumor Analysis Consortium.